Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 2 |
GO:0005851 | eukaryotic translation initiation factor 2B complex | 2 | 2 |
GO:0032991 | protein-containing complex | 1 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 3 |
GO:0016020 | membrane | 2 | 1 |
Related structures:
AlphaFold database: Q4QHB9
Term | Name | Level | Count |
---|---|---|---|
GO:0006413 | translational initiation | 3 | 2 |
GO:0008152 | metabolic process | 1 | 2 |
GO:0009987 | cellular process | 1 | 2 |
GO:0044237 | cellular metabolic process | 2 | 2 |
GO:0050790 | regulation of catalytic activity | 3 | 2 |
GO:0065007 | biological regulation | 1 | 2 |
GO:0065009 | regulation of molecular function | 2 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 10 |
GO:0003743 | translation initiation factor activity | 4 | 10 |
GO:0005488 | binding | 1 | 10 |
GO:0008135 | translation factor activity, RNA binding | 3 | 10 |
GO:0045182 | translation regulator activity | 1 | 10 |
GO:0090079 | translation regulator activity, nucleic acid binding | 2 | 10 |
GO:0097159 | organic cyclic compound binding | 2 | 10 |
GO:1901363 | heterocyclic compound binding | 2 | 10 |
GO:0003824 | catalytic activity | 1 | 1 |
GO:0016853 | isomerase activity | 2 | 1 |
GO:0016860 | intramolecular oxidoreductase activity | 3 | 1 |
GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses | 4 | 1 |
GO:0046523 | S-methyl-5-thioribose-1-phosphate isomerase activity | 5 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 295 | 299 | PF00656 | 0.563 |
CLV_C14_Caspase3-7 | 483 | 487 | PF00656 | 0.560 |
CLV_NRD_NRD_1 | 119 | 121 | PF00675 | 0.376 |
CLV_NRD_NRD_1 | 207 | 209 | PF00675 | 0.656 |
CLV_NRD_NRD_1 | 316 | 318 | PF00675 | 0.356 |
CLV_NRD_NRD_1 | 338 | 340 | PF00675 | 0.356 |
CLV_NRD_NRD_1 | 489 | 491 | PF00675 | 0.370 |
CLV_PCSK_KEX2_1 | 119 | 121 | PF00082 | 0.376 |
CLV_PCSK_KEX2_1 | 196 | 198 | PF00082 | 0.692 |
CLV_PCSK_KEX2_1 | 207 | 209 | PF00082 | 0.588 |
CLV_PCSK_KEX2_1 | 266 | 268 | PF00082 | 0.629 |
CLV_PCSK_KEX2_1 | 28 | 30 | PF00082 | 0.501 |
CLV_PCSK_KEX2_1 | 304 | 306 | PF00082 | 0.347 |
CLV_PCSK_KEX2_1 | 316 | 318 | PF00082 | 0.285 |
CLV_PCSK_KEX2_1 | 338 | 340 | PF00082 | 0.356 |
CLV_PCSK_KEX2_1 | 489 | 491 | PF00082 | 0.370 |
CLV_PCSK_PC1ET2_1 | 196 | 198 | PF00082 | 0.785 |
CLV_PCSK_PC1ET2_1 | 266 | 268 | PF00082 | 0.721 |
CLV_PCSK_PC1ET2_1 | 28 | 30 | PF00082 | 0.575 |
CLV_PCSK_PC1ET2_1 | 304 | 306 | PF00082 | 0.347 |
CLV_PCSK_PC7_1 | 262 | 268 | PF00082 | 0.663 |
CLV_PCSK_SKI1_1 | 119 | 123 | PF00082 | 0.386 |
CLV_PCSK_SKI1_1 | 144 | 148 | PF00082 | 0.565 |
CLV_PCSK_SKI1_1 | 189 | 193 | PF00082 | 0.791 |
CLV_PCSK_SKI1_1 | 262 | 266 | PF00082 | 0.679 |
CLV_PCSK_SKI1_1 | 339 | 343 | PF00082 | 0.356 |
CLV_PCSK_SKI1_1 | 376 | 380 | PF00082 | 0.360 |
CLV_PCSK_SKI1_1 | 489 | 493 | PF00082 | 0.356 |
DEG_APCC_DBOX_1 | 118 | 126 | PF00400 | 0.384 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.710 |
DEG_SCF_FBW7_1 | 158 | 165 | PF00400 | 0.701 |
DEG_SCF_TRCP1_1 | 486 | 492 | PF00400 | 0.577 |
DEG_SPOP_SBC_1 | 163 | 167 | PF00917 | 0.751 |
DEG_SPOP_SBC_1 | 215 | 219 | PF00917 | 0.618 |
DEG_SPOP_SBC_1 | 433 | 437 | PF00917 | 0.507 |
DOC_CKS1_1 | 159 | 164 | PF01111 | 0.778 |
DOC_CYCLIN_RxL_1 | 335 | 343 | PF00134 | 0.556 |
DOC_CYCLIN_RxL_1 | 89 | 100 | PF00134 | 0.460 |
DOC_MAPK_gen_1 | 207 | 214 | PF00069 | 0.736 |
DOC_MAPK_MEF2A_6 | 207 | 214 | PF00069 | 0.736 |
DOC_MAPK_MEF2A_6 | 425 | 433 | PF00069 | 0.490 |
DOC_PP4_FxxP_1 | 243 | 246 | PF00568 | 0.739 |
DOC_PP4_FxxP_1 | 427 | 430 | PF00568 | 0.476 |
DOC_USP7_MATH_1 | 129 | 133 | PF00917 | 0.505 |
DOC_USP7_MATH_1 | 163 | 167 | PF00917 | 0.751 |
DOC_USP7_MATH_1 | 182 | 186 | PF00917 | 0.721 |
DOC_USP7_MATH_1 | 215 | 219 | PF00917 | 0.722 |
DOC_USP7_MATH_1 | 34 | 38 | PF00917 | 0.691 |
DOC_USP7_MATH_1 | 372 | 376 | PF00917 | 0.529 |
DOC_USP7_MATH_1 | 384 | 388 | PF00917 | 0.421 |
DOC_USP7_UBL2_3 | 192 | 196 | PF12436 | 0.746 |
DOC_WW_Pin1_4 | 158 | 163 | PF00397 | 0.708 |
DOC_WW_Pin1_4 | 180 | 185 | PF00397 | 0.671 |
DOC_WW_Pin1_4 | 438 | 443 | PF00397 | 0.490 |
DOC_WW_Pin1_4 | 468 | 473 | PF00397 | 0.495 |
DOC_WW_Pin1_4 | 475 | 480 | PF00397 | 0.482 |
LIG_14-3-3_CanoR_1 | 207 | 213 | PF00244 | 0.665 |
LIG_14-3-3_CanoR_1 | 316 | 322 | PF00244 | 0.520 |
LIG_14-3-3_CanoR_1 | 376 | 384 | PF00244 | 0.560 |
LIG_Actin_WH2_2 | 12 | 30 | PF00022 | 0.505 |
LIG_Actin_WH2_2 | 252 | 268 | PF00022 | 0.629 |
LIG_Actin_WH2_2 | 426 | 441 | PF00022 | 0.476 |
LIG_BRCT_BRCA1_1 | 210 | 214 | PF00533 | 0.743 |
LIG_deltaCOP1_diTrp_1 | 473 | 480 | PF00928 | 0.542 |
LIG_eIF4E_1 | 500 | 506 | PF01652 | 0.476 |
LIG_FHA_1 | 109 | 115 | PF00498 | 0.430 |
LIG_FHA_1 | 116 | 122 | PF00498 | 0.355 |
LIG_FHA_1 | 249 | 255 | PF00498 | 0.696 |
LIG_FHA_1 | 309 | 315 | PF00498 | 0.513 |
LIG_FHA_1 | 317 | 323 | PF00498 | 0.461 |
LIG_FHA_1 | 377 | 383 | PF00498 | 0.544 |
LIG_FHA_1 | 394 | 400 | PF00498 | 0.395 |
LIG_FHA_1 | 415 | 421 | PF00498 | 0.476 |
LIG_FHA_1 | 433 | 439 | PF00498 | 0.476 |
LIG_FHA_1 | 449 | 455 | PF00498 | 0.467 |
LIG_FHA_1 | 496 | 502 | PF00498 | 0.478 |
LIG_FHA_1 | 505 | 511 | PF00498 | 0.481 |
LIG_FHA_1 | 70 | 76 | PF00498 | 0.466 |
LIG_FHA_2 | 133 | 139 | PF00498 | 0.591 |
LIG_FHA_2 | 159 | 165 | PF00498 | 0.751 |
LIG_FHA_2 | 217 | 223 | PF00498 | 0.671 |
LIG_LIR_Apic_2 | 241 | 246 | PF02991 | 0.741 |
LIG_LIR_Apic_2 | 467 | 472 | PF02991 | 0.478 |
LIG_LIR_Apic_2 | 473 | 479 | PF02991 | 0.473 |
LIG_LIR_Apic_2 | 498 | 503 | PF02991 | 0.476 |
LIG_LIR_Gen_1 | 386 | 394 | PF02991 | 0.538 |
LIG_LIR_Nem_3 | 463 | 469 | PF02991 | 0.473 |
LIG_MYND_2 | 502 | 506 | PF01753 | 0.490 |
LIG_PCNA_PIPBox_1 | 54 | 63 | PF02747 | 0.461 |
LIG_Pex14_1 | 476 | 480 | PF04695 | 0.556 |
LIG_Pex14_2 | 109 | 113 | PF04695 | 0.557 |
LIG_SH2_NCK_1 | 529 | 533 | PF00017 | 0.556 |
LIG_SH2_PTP2 | 500 | 503 | PF00017 | 0.476 |
LIG_SH2_SRC | 293 | 296 | PF00017 | 0.577 |
LIG_SH2_SRC | 500 | 503 | PF00017 | 0.476 |
LIG_SH2_STAT5 | 340 | 343 | PF00017 | 0.490 |
LIG_SH2_STAT5 | 389 | 392 | PF00017 | 0.556 |
LIG_SH2_STAT5 | 500 | 503 | PF00017 | 0.464 |
LIG_SH3_1 | 439 | 445 | PF00018 | 0.490 |
LIG_SH3_2 | 6 | 11 | PF14604 | 0.449 |
LIG_SH3_3 | 156 | 162 | PF00018 | 0.709 |
LIG_SH3_3 | 178 | 184 | PF00018 | 0.754 |
LIG_SH3_3 | 198 | 204 | PF00018 | 0.776 |
LIG_SH3_3 | 3 | 9 | PF00018 | 0.533 |
LIG_SH3_3 | 439 | 445 | PF00018 | 0.490 |
LIG_SH3_4 | 192 | 199 | PF00018 | 0.748 |
LIG_SUMO_SIM_anti_2 | 91 | 97 | PF11976 | 0.463 |
LIG_SUMO_SIM_par_1 | 429 | 437 | PF11976 | 0.476 |
LIG_SxIP_EBH_1 | 252 | 266 | PF03271 | 0.726 |
LIG_TRAF2_1 | 220 | 223 | PF00917 | 0.768 |
LIG_TRAF2_1 | 365 | 368 | PF00917 | 0.553 |
MOD_CK1_1 | 132 | 138 | PF00069 | 0.533 |
MOD_CK1_1 | 166 | 172 | PF00069 | 0.692 |
MOD_CK1_1 | 218 | 224 | PF00069 | 0.769 |
MOD_CK1_1 | 238 | 244 | PF00069 | 0.778 |
MOD_CK1_1 | 324 | 330 | PF00069 | 0.534 |
MOD_CK1_1 | 393 | 399 | PF00069 | 0.528 |
MOD_CK1_1 | 41 | 47 | PF00069 | 0.449 |
MOD_CK1_1 | 414 | 420 | PF00069 | 0.560 |
MOD_CK2_1 | 132 | 138 | PF00069 | 0.505 |
MOD_CK2_1 | 149 | 155 | PF00069 | 0.538 |
MOD_CK2_1 | 216 | 222 | PF00069 | 0.689 |
MOD_CK2_1 | 267 | 273 | PF00069 | 0.629 |
MOD_CK2_1 | 34 | 40 | PF00069 | 0.648 |
MOD_Cter_Amidation | 487 | 490 | PF01082 | 0.360 |
MOD_GlcNHglycan | 127 | 130 | PF01048 | 0.474 |
MOD_GlcNHglycan | 186 | 189 | PF01048 | 0.665 |
MOD_GlcNHglycan | 222 | 227 | PF01048 | 0.746 |
MOD_GlcNHglycan | 36 | 39 | PF01048 | 0.599 |
MOD_GlcNHglycan | 385 | 389 | PF01048 | 0.279 |
MOD_GlcNHglycan | 458 | 461 | PF01048 | 0.308 |
MOD_GlcNHglycan | 486 | 489 | PF01048 | 0.311 |
MOD_GSK3_1 | 125 | 132 | PF00069 | 0.542 |
MOD_GSK3_1 | 158 | 165 | PF00069 | 0.707 |
MOD_GSK3_1 | 176 | 183 | PF00069 | 0.651 |
MOD_GSK3_1 | 199 | 206 | PF00069 | 0.710 |
MOD_GSK3_1 | 214 | 221 | PF00069 | 0.651 |
MOD_GSK3_1 | 234 | 241 | PF00069 | 0.767 |
MOD_GSK3_1 | 250 | 257 | PF00069 | 0.615 |
MOD_GSK3_1 | 327 | 334 | PF00069 | 0.476 |
MOD_GSK3_1 | 34 | 41 | PF00069 | 0.570 |
MOD_GSK3_1 | 372 | 379 | PF00069 | 0.572 |
MOD_GSK3_1 | 434 | 441 | PF00069 | 0.476 |
MOD_GSK3_1 | 464 | 471 | PF00069 | 0.538 |
MOD_GSK3_1 | 480 | 487 | PF00069 | 0.534 |
MOD_GSK3_1 | 504 | 511 | PF00069 | 0.471 |
MOD_GSK3_1 | 84 | 91 | PF00069 | 0.444 |
MOD_N-GLC_1 | 115 | 120 | PF02516 | 0.372 |
MOD_N-GLC_1 | 511 | 516 | PF02516 | 0.337 |
MOD_N-GLC_1 | 527 | 532 | PF02516 | 0.473 |
MOD_N-GLC_2 | 171 | 173 | PF02516 | 0.647 |
MOD_NEK2_1 | 115 | 120 | PF00069 | 0.380 |
MOD_NEK2_1 | 214 | 219 | PF00069 | 0.719 |
MOD_NEK2_1 | 248 | 253 | PF00069 | 0.728 |
MOD_NEK2_1 | 331 | 336 | PF00069 | 0.508 |
MOD_NEK2_1 | 411 | 416 | PF00069 | 0.524 |
MOD_NEK2_1 | 432 | 437 | PF00069 | 0.476 |
MOD_NEK2_1 | 480 | 485 | PF00069 | 0.560 |
MOD_NEK2_1 | 68 | 73 | PF00069 | 0.568 |
MOD_NEK2_1 | 88 | 93 | PF00069 | 0.435 |
MOD_NEK2_2 | 333 | 338 | PF00069 | 0.556 |
MOD_NEK2_2 | 434 | 439 | PF00069 | 0.507 |
MOD_PIKK_1 | 199 | 205 | PF00454 | 0.758 |
MOD_PIKK_1 | 363 | 369 | PF00454 | 0.507 |
MOD_PIKK_1 | 516 | 522 | PF00454 | 0.431 |
MOD_PK_1 | 120 | 126 | PF00069 | 0.461 |
MOD_PK_1 | 208 | 214 | PF00069 | 0.746 |
MOD_PKA_1 | 196 | 202 | PF00069 | 0.778 |
MOD_PKA_1 | 316 | 322 | PF00069 | 0.560 |
MOD_PKA_1 | 489 | 495 | PF00069 | 0.560 |
MOD_PKA_2 | 125 | 131 | PF00069 | 0.504 |
MOD_PKA_2 | 196 | 202 | PF00069 | 0.701 |
MOD_PKA_2 | 315 | 321 | PF00069 | 0.559 |
MOD_PKA_2 | 489 | 495 | PF00069 | 0.560 |
MOD_Plk_1 | 384 | 390 | PF00069 | 0.470 |
MOD_Plk_2-3 | 149 | 155 | PF00069 | 0.635 |
MOD_Plk_2-3 | 308 | 314 | PF00069 | 0.553 |
MOD_Plk_4 | 108 | 114 | PF00069 | 0.494 |
MOD_Plk_4 | 120 | 126 | PF00069 | 0.391 |
MOD_Plk_4 | 142 | 148 | PF00069 | 0.611 |
MOD_Plk_4 | 196 | 202 | PF00069 | 0.727 |
MOD_Plk_4 | 250 | 256 | PF00069 | 0.655 |
MOD_Plk_4 | 324 | 330 | PF00069 | 0.507 |
MOD_Plk_4 | 53 | 59 | PF00069 | 0.448 |
MOD_ProDKin_1 | 158 | 164 | PF00069 | 0.710 |
MOD_ProDKin_1 | 180 | 186 | PF00069 | 0.673 |
MOD_ProDKin_1 | 438 | 444 | PF00069 | 0.490 |
MOD_ProDKin_1 | 468 | 474 | PF00069 | 0.495 |
MOD_ProDKin_1 | 475 | 481 | PF00069 | 0.482 |
MOD_SUMO_for_1 | 303 | 306 | PF00179 | 0.556 |
MOD_SUMO_rev_2 | 136 | 146 | PF00179 | 0.587 |
TRG_DiLeu_BaEn_1 | 8 | 13 | PF01217 | 0.483 |
TRG_DiLeu_BaLyEn_6 | 243 | 248 | PF01217 | 0.738 |
TRG_DiLeu_BaLyEn_6 | 89 | 94 | PF01217 | 0.430 |
TRG_ENDOCYTIC_2 | 389 | 392 | PF00928 | 0.556 |
TRG_ER_diArg_1 | 119 | 121 | PF00400 | 0.376 |
TRG_ER_diArg_1 | 337 | 339 | PF00400 | 0.556 |
TRG_ER_diArg_1 | 489 | 491 | PF00400 | 0.572 |
TRG_NES_CRM1_1 | 49 | 62 | PF08389 | 0.524 |
TRG_Pf-PMV_PEXEL_1 | 230 | 234 | PF00026 | 0.798 |
TRG_Pf-PMV_PEXEL_1 | 339 | 343 | PF00026 | 0.356 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P3U6 | Leptomonas seymouri | 72% | 100% |
A0A0S4JL98 | Bodo saltans | 38% | 89% |
A0A1X0NQN7 | Trypanosomatidae | 48% | 100% |
A0A3S7WRA1 | Leishmania donovani | 98% | 100% |
A0A422NCU2 | Trypanosoma rangeli | 45% | 100% |
A4HUK8 | Leishmania infantum | 98% | 100% |
E9ANA5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 97% | 100% |
V5BTT5 | Trypanosoma cruzi | 46% | 100% |